Earli logo

Earli

Turning Cancer Against Itself.

36 employees · est. 2018 · Redwood City, United States

VS
Tango Therapeutics logo

Tango Therapeutics

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.

157 employees · est. 2017 · Boston, United States

Tango Therapeutics is the older company (2018 vs 2017); Tango Therapeutics is the larger of the two.

Side-by-Side Comparison

Earli Tango Therapeutics
Founded
2018 2017 older
Headquarters
Redwood City, United States Boston, United States
Employees
36 157 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Unknown Post Ipo Equity
Total Funding
$59.50M $351.00M
Funding Rounds
4 4
Services
Not tracked yet Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations
Target Customers
Not tracked yet Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors
Taxonomy
Not tracked yet Clinical-stage, Precision Medicine, Cancer Treatment, Tumor Suppressor Targeting, Synthetic Lethality, CRISPR-based Discovery, DNA Sequencing, Immuno-oncology, Oncogenic Drivers, Immune Evasion, Functional Genomics, Drug Discovery, Targeted Therapies, Novel Drug Targets
Website
earli.com tangotx.com
Earli logo

About Earli

Earli mission is to make cancer a benign experience by turning cancer against itself. Earli creates genetic constructs that turn on only in cancer cells and then re-program the cancer cells to produce their own therapies, to kill themselves. Earli has been funded by Andreessen Horowitz's a16z B...

Tango Therapeutics logo

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...

We will tell you when either one moves

BounceWatch watches Earli and Tango Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Earli and Tango Therapeutics — by email.

Frequently Asked Questions

Earli — Turning Cancer Against Itself.. Tango Therapeutics — Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Earli has raised $59.50M while Tango Therapeutics has raised $351.00M.
Earli and Tango Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Earli with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Earli on 9 Jun 2026, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy